Key result
Declining renal function in myocardial infarction patients was associated with less frequent use of guideline-directed therapies and an increase in in-hospital mortality from 2.5% to 24.2%.
Why the study?
Does renal insufficiency affect clinical presentation, use of therapies, and in-hospital complications in patients with myocardial infarction?
Observational (n=57,477)
Yes
Does renal insufficiency affect clinical presentation, use of therapies, and in-hospital complications in patients with myocardial infarction?
Renal insufficiency in myocardial infarction patients is associated with atypical presentation, underutilization of guideline-directed therapies, and significantly higher in-hospital mortality.
Answers are grounded in this paper and cite their sources.
Renal decline flags high-risk MI patients for closer monitoring; leaves open whether addressing GDMT gaps improves survival.
Szummer K, Lundman P, Jacobson SH, Schön S, Lindbäck J, Stenestrand U, Wallentin L, Jernberg T, for SWEDEHEART. (Karolinska Institute, Karolinska University Hospital, Stockholm; Karolinska Institute, Danderyd Hospital, Danderyd; Ryhov County Hospital, Jönköping; University Hospital, Uppsala and University Hospital, Linköping; Sweden) Relation between renal function, presentation, use of therapies and in‐hospital complications in acute coronary syndrome: data from the SWEDEHEART register. J Intern Med 2010; 268 :40–49. Objective. To examine clinical characteristics, presenting symptoms, use of therapy and in‐hospital complications in relation to renal function in patients with myocardial infarction (MI). Design. Observational study. Setting. Nationwide coronary care unit registry between 2003–2006 in Sweden. Subjects. Consecutive MI patients with available creatinine ( n = 57 477). Results. Glomerular filtration rate was estimated with the Modification of Diet in Renal Disease Study formula. With declining renal function patients were older, had more co‐morbidities and more often used cardio‐protective medication on admission. Compared to patients with normal renal function, fewer with renal failure presented with chest pain (90% vs. 67%, P < 0.001), Killip I (89% vs. 58%, P < 0.001) and ST‐elevation myocardial infarction (STEMI) (41% vs. 22%, P < 0.001). In a logistic regression model lower renal function was independently associated with a less frequent use of anticoagulant and revascularization in non‐ST‐elevation MI. The likelihood of receiving reperfusion therapy for STEMI was similar in patients with normal‐to‐moderate renal dysfunction, but decreased in severe renal dysfunction or renal failure. Reperfusion therapy shifted from primary percutaneous coronary intervention in 71% of patients with normal renal function to fibrinolysis in 58% of those with renal failure. Renal function was associated with a higher rate of complications and an exponential increase in in‐hospital mortality from 2.5% to 24.2% across the renal function groups. Conclusion. Renal insufficiency influences the presentation and reduces the likelihood of receiving treatment according to current guidelines. Short‐term prognosis remains poor.
No takes yet. Share an insight, caveat, or question.
Szummer et al. (2009) conducted an observational in myocardial infarction (MI) (n=57,477). Declining renal function vs. Normal renal function was evaluated on in-hospital mortality. Declining renal function in myocardial infarction patients was associated with less frequent use of guideline-directed therapies and an increase in in-hospital mortality from 2.5% to 24.2%.
Synapse has enriched 10 related papers. Consider them for comparative context: